Eurofins Scientific SEEURONEXT: ERF

Eurofins Scientific: Director/PDMR Shareholding

· Issued by Eurofins Scientific SE via Business Wire

Summary by 6ix AI

François Vigneau, a Senior Vice President at Eurofins Scientific SE, sold 750 Eurofins shares at EUR 88.2492 each on November 6, 2026. Eurofins, a bio-analysis testing company, disclosed the sale as a dealing by a senior manager under the European Market Abuse Regulation.

Key details

  • The sale is linked to the Eurofins stock option / free share program.
  • The aggregated figure for the sale is given as EUR 66,186.90.
  • This is an initial notification, not an amendment.

6ix AI wrote this summary from the release below and checked it against the release.

Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.

This notification is made in accordance with the European Market Abuse Regulation.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

VIGNEAU François

2.

Reason for the notification

a)

Position / status

Senior Vice President

b)

Initial notification / amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Eurofins Scientific S.E.

b)

LEI

529900JEHFM47DYY3S57

4.

Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Share

Identification code

ISIN: FR0014000MR3

b)

Nature of the transaction

Sale of shares

Transaction is linked to the Eurofins stock option / free share / stock option program

c)

Price(s) and volume(s)

Price(s)

Volume(s)

EUR 88.2492

750

d)

Aggregated information

— Aggregated volume

EUR 66,186.90

— Price

EUR 88.2492

e)

Date of the transaction

2026-11-06

g)

Place of the transaction

XPAR

For more information, please visit www.eurofins.com.

About Eurofins – the global leader in bio-analysis

Eurofins is Testing for Life. With over 65,000 staff across a network of more than 950 laboratories in over 1,000 companies in 57 countries, Eurofins offers a portfolio of over 200,000 analytical methods.

Eurofins Scientific S.E. shares are listed on Euronext Paris Stock Exchange.

View original source (Business Wire)Eurofins Scientific SE on 6ix

Earlier from Eurofins Scientific

Later from Eurofins Scientific

All Eurofins Scientific news releases